Who cares about oligozoospermia when we have ICSI

Area of Science:

• Reproductive Medicine
• Andrology
• Genetics

Background:

• The value of evaluating subfertile males with oligozoospermia is debated, with a tendency to offer intracytoplasmic sperm injection (ICSI) without addressing underlying causes.
• Oligozoospermia is linked to poor male reproductive health, sperm DNA damage, and potential adverse effects on offspring.
• Numerous conditions, including varicocele, infections, genetic defects, lifestyle factors, and environmental exposures, can cause oligozoospermia.

Purpose of the Study:

• To emphasize the importance of diagnosing and treating oligozoospermia in subfertile males.
• To highlight the potential adverse effects of indiscriminately offering ICSI.
• To advocate for a comprehensive male infertility evaluation as a critical step in fertility management.

Main Methods:

• Review of recent data associating oligozoospermia with male reproductive health and offspring outcomes.
• Discussion of various etiological factors contributing to oligozoospermia.
• Emphasis on the role of andrological assessment and therapeutic interventions.

Main Results:

• Therapeutic interventions for oligozoospermia can improve sperm parameters and male health, leading to better pregnancy outcomes.
• A thorough male infertility evaluation can identify treatable conditions and guide optimal use of ICSI.
• Addressing oligozoospermia positively impacts patient health, couple's fertility, and offspring well-being.

Conclusions:

• Comprehensive evaluation and treatment of oligozoospermia are essential for subfertile males.
• Fertility clinics should involve male infertility specialists for optimal diagnosis and management.
• Focusing on male reproductive health improves overall patient outcomes and offspring health.